A framework for in-field and out-of-field patient specific secondary cancer risk estimates from treatment plans using the TOPAS Monte Carlo system.

Monte Carlo dose calculation computational phantoms out-of-field dose second cancer risk

Journal

Physics in medicine and biology
ISSN: 1361-6560
Titre abrégé: Phys Med Biol
Pays: England
ID NLM: 0401220

Informations de publication

Date de publication:
17 Jul 2024
Historique:
medline: 18 7 2024
pubmed: 18 7 2024
entrez: 17 7 2024
Statut: aheadofprint

Résumé

To allow the estimation of secondary cancer risks from radiation therapy treatment plans in a comprehensive and user-friendly Monte Carlo framework. 
Approach: Patient planning CTs were extended superior-inferior using the ICRP Publication 145 computational mesh phantoms and skeletal matching. Dose distributions were calculated with the TOPAS Monte Carlo system using novel mesh capabilities and the DICOM-RT interface. Finally, in-field and out-of-field cancer risk was calculated using both sarcoma and carcinoma risk models with two alternative parameter sets.
Main results: The TOPAS Monte Carlo framework was extended to facilitate epidemiological studies on radiation-induced cancer risk. The framework is efficient and allows automated analysis of large datasets. Out-of-field organ dose was small compared to in-field dose, but the risk estimates indicate a non-negligible contribution to the total radiation induced cancer risk. 
Significance: The implementation of anatomical extension, mesh phantom capabilities, and cancer risk models into the TOPAS Monte Carlo system makes state-of-the-art out-of-field dose calculation and risk estimation accessible to a large pool of users while facilitating further refinement of risk models and sensitivity analysis of patient specific treatment options.

Identifiants

pubmed: 39019051
doi: 10.1088/1361-6560/ad64b6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 Institute of Physics and Engineering in Medicine.

Auteurs

Isaac Meyer (I)

Department of Radiation Oncology, Physics Division, Massachusetts General Hospital and Harvard Medical School, 125 Nashua St, Boston, Massachusetts, 02114, UNITED STATES.

Nils Peters (N)

Department of Radiation Oncology, Physics Division, Massachusetts General Hospital and Harvard Medical School, 125 Nashua St, Boston, Massachusetts, 02114, UNITED STATES.

Giulia Tamborino (G)

Department of Radiation Oncology, Physics Division, Massachusetts General Hospital and Harvard Medical School, 125 Nashua St, Boston, Massachusetts, 02114, UNITED STATES.

Hoyeon Lee (H)

Department of Radiation Oncology, Physics Division, Massachusetts General Hospital and Harvard Medical School, 125 Nashua St, Boston, Massachusetts, 02114, UNITED STATES.

Alejandro Bertolet (A)

Department of Radiation Oncology, Physics Division, Massachusetts General Hospital and Harvard Medical School, 125 Nashua St, Boston, Massachusetts, 02114, UNITED STATES.

Bruce A Faddegon (BA)

Department of Radiation Oncology, University of California San Francisco, 1600 Divisadero Street, San Francisco, California, 94143, UNITED STATES.

Matthew M Mille (MM)

Radiation Epidemiology Branch, National Cancer Institute, 9609 Medical Center Drive, Rockville, Maryland, 20850, UNITED STATES.

Choonsik Lee (C)

Radiation Epidemiology Branch, National Cancer Institute, 9609 Medical Center Drive, Rockville, Maryland, 20850, UNITED STATES.

Jan Schuemann (J)

Department of Radiation Oncology, Physics Division, Massachusetts General Hospital and Harvard Medical School, 125 Nashua St, Boston, Massachusetts, 02114, UNITED STATES.

Harald Paganetti (H)

Department of Radiation Oncology, Physics Division, Massachusetts General Hospital and Harvard Medical School, 125 Nashua St, Boston, Massachusetts, 02114, UNITED STATES.

Classifications MeSH